Does a quick phone scan show my real age for better insurance rates?

When an applicant asks whether a 30-second phone scan can reveal their "real age" for a better rate, they are pointing at a question the insurance industry has spent the last few years trying to answer with hard data. A mobile underwriting health assessment does not literally read a birth certificate off a face. What it estimates is something more useful for pricing risk: biological age, or how the body is actually performing relative to the calendar. For underwriting leaders, the distinction matters because chronological age has always been a blunt proxy for mortality, and the technology to measure something sharper now fits inside a smartphone camera.

"Participants with an AI-derived photoplethysmography age gap greater than 9 years had a 2.37 times higher risk of major adverse cardiovascular and cerebrovascular events," reported the research team behind a 2024 study published in npj Digital Medicine, drawing on 212,231 UK Biobank participants.

That figure captures why the conversation has moved past novelty. The gap between measured biological age and stated age is not cosmetic. It tracks with outcomes underwriters already price for.

What a mobile underwriting health assessment actually measures

A mobile underwriting health assessment uses the smartphone camera to capture subtle color changes in facial skin caused by blood flow, a technique called remote or transdermal photoplethysmography (PPG). From that signal, models estimate heart rate, heart rate variability, an approximation of blood pressure category, respiration, and a composite biological or "facial" age. The scan typically runs 30 seconds and produces structured data rather than a single number.

The reason this is relevant to pricing is that chronological age is correlated with mortality but does not explain individual variation. Two 45-year-old applicants can carry very different cardiovascular risk. Traditional underwriting closed that gap with fluids, exams, and attending physician statements. A mobile assessment tries to close part of it instantly, at the point of application, before an applicant abandons the funnel.

The foundational science predates the phone hardware. Morgan Levine and colleagues at Yale introduced "phenotypic age" in 2018, a biological age measure built from nine clinical biomarkers that outperformed chronological age as a predictor of all-cause mortality. Mobile assessment vendors are chasing the same target, biological age, through a camera instead of a blood draw. The validation bar is whether the signal still carries mortality and morbidity information when the input is optical rather than serological.

Here is how the main screening modalities compare on the dimensions underwriting teams weigh.

Dimension	Chronological age only	Mobile underwriting health assessment	Traditional paramedical exam
Time to complete	Instant	About 30 seconds	3 to 10 days to schedule and process
Cost per applicant	Negligible	Low, software-based	$75 to $150 typical
Data richness	Single variable	Heart rate, HRV, BP category, biological age estimate	Fluids, build, blood pressure, labs
Placement in funnel	Application form	Point of application	Post-application, adds delay
Captures individual variation	No	Partial	High
Applicant drop-off risk	None	Low	Elevated

The table makes the strategic tension visible. The paramedical exam still wins on raw data depth, but it carries cost and friction that push applicants out of the funnel. A mobile assessment sits between doing nothing and ordering fluids, and that middle ground is where most accelerated underwriting programs now operate.

Key things a mobile assessment can and cannot do:

• It can flag elevated cardiovascular risk signals worth a closer look.
• It can provide a continuous risk variable rather than a yes or no.
• It can run at the moment of application with no scheduling.
• It cannot replace a lab panel for conditions that require chemistry.
• It cannot confirm a specific diagnosis on its own.

Industry applications across the underwriting funnel

Accelerated underwriting triage

The most direct use is triage. According to LIMRA's 2024 Accelerated Underwriting Study, 80 percent of life carriers now offer some form of accelerated underwriting and 60 percent offer it with no medical exam. A mobile assessment gives these programs a physiological data point to confirm low-risk applicants for instant approval and route ambiguous cases to fuller review. The biological age estimate becomes one input in a rules engine, not the sole decision.

Final expense and simplified issue

In segments that historically skipped exams entirely and relied on a handful of knockout questions, any objective physiological signal is additive. A scan adds structured data where there was previously only self-report, which can tighten pricing on a population that is otherwise underwritten almost blind.

Reach and distribution

Reinsurer RGA has noted in its analysis of PPG solutions that the affordability and smartphone delivery of the technology make it attractive for population-scale screening. For carriers chasing the underinsured middle market, a phone-native assessment removes the geographic and scheduling barriers that an in-person exam imposes.

Current research and evidence

The evidence base is maturing along two tracks. The first is the biological age science itself. Levine's 2018 phenotypic age work established that a well-constructed biological age measure beats chronological age for mortality prediction, which is the entire premise behind measuring "real age."

The second track is whether optical, camera-based signals carry the same predictive weight. The 2024 npj Digital Medicine study on AI-derived PPG age is the most relevant data point for underwriters. Trained on 212,231 UK Biobank participants and externally validated on an independent MIMIC-III cohort of 2,343 patients, the model found that each one-year increase in the PPG age gap raised in-hospital mortality odds (odds ratio 1.02, p = 0.01), and that a gap above 9 years more than doubled cardiovascular event risk. That is direct evidence that a PPG-derived age gap behaves like a mortality-relevant biomarker, which is exactly the property a life underwriter needs.

Caveats remain honest and important. Much of the published validation uses contact PPG or research-grade signals rather than consumer phone cameras in uncontrolled lighting. Generalizability across skin tones, devices, and motion conditions is an active area of scrutiny, and underwriting teams should demand modality-matched validation rather than borrowing results from adjacent hardware. The direction of the science is encouraging, but the burden of proof sits with vendor-specific, population-representative testing.

The future of mobile underwriting health assessment

Three shifts look likely over the next few years. First, the assessment moves from a binary triage gate to a continuous risk variable feeding the pricing model directly, with the biological age gap weighted alongside traditional factors. Second, expect tighter regulatory and fairness scrutiny. As scans influence price, carriers will need to demonstrate the model performs consistently across demographic groups, and regulators will ask for it. Third, the data will likely become longitudinal. A scan at application is a snapshot; periodic rescans could support dynamic pricing and wellness-linked products where improving biological age is rewarded.

The competitive pressure is straightforward. Carriers that can price individual variation at the point of application convert more low-risk applicants faster while routing genuine risk to deeper review. The "real age" question consumers ask is, underneath, the same question underwriters have always asked. Mobile assessment is the first tool that lets both sides ask it at the same moment.

Frequently asked questions

Does a phone scan literally detect my age? No. It estimates biological age, a measure of how your cardiovascular and physiological systems are performing, which can differ from your calendar age in either direction. That estimate is what carries risk information for pricing.

Can a mobile underwriting health assessment replace blood work? Not entirely. It captures cardiovascular and physiological signals quickly and cheaply, but lab chemistry still detects conditions a camera cannot. Most programs use a scan to triage and reserve fluids for cases that need them.

Will a good scan actually lower my insurance rate? It can support faster approval and, in programs that use biological age as a pricing variable, a healthier-than-average profile can help. The scan is one input among many, not a guaranteed discount.

How reliable is the biological age estimate? Research on PPG-derived age shows meaningful association with mortality and cardiovascular events, but reliability depends on the specific model, hardware, and validation population. Underwriters should require validation matched to the exact phone-camera modality being deployed.

Circadify is building in this space, developing phone-native health assessment technology designed to fit accelerated underwriting workflows. Product managers and underwriting leaders evaluating mobile assessment can review demos and integration guides at circadify.com/industries/payers-insurance.